Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech stocks increased.
Published:
Last Updated:
Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study of patients with follicular lymphoma.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Capital One, Celgene, Conagra Brands, Honeywell, 3M, Nike, Sempra Energy and SunPower.
Published:
Last Updated:
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
Published:
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech stocks was mixed.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Aetna, Alphabet, Amazon, Celgene, First Solar, Intel, IBM, Microsoft, Tesla and Twitter.
Published:
Last Updated:
Thursday was relatively positive day for the markets, with the Dow and S&P 500 posting decent gains for the day. Crude oil started out flat but came on strong Thursday afternoon. The S&P 500...
Published:
Last Updated:
General Electric, Celgene, Chesapeake Energy, and Southwestern Energy all posted new 52-week lows Thursday.
Published:
Last Updated:
Despite mixed results, with earnings were fairly positive for the quarter, this was not enough to outweigh poor guidance. Shares sank to a new 52-week low.
Published:
Last Updated:
The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.
Published:
Last Updated:
Friday was a very positive day for the broad U.S. markets closing out a record week for all three. The Dow continues to hold above 23,000 and is almost a third of the way to 24,000. Crude oil...
Published:
Last Updated: